The coronavirus has become a global concern ever since it broke out in China in 2019. As cases rise, a nurse claims that there may be another condition that may indicate the presence of the disease.
Express reports that a nurse from Kirkland, Washington, Chelsey Earnest, revealed a possible new symptom of coronavirus. Earnest reported that red eyes or conjunctivitis may indicate the presence of COVID19. Speaking to CNN, Earnest, who has been treating patients at the epicenter, explained what she observed among the patients she was helping treat. “The white part of the eye is not red. It’s more like they have red eyeshadow on the outside of their eyes...We’ve had patients that just had the red eyes as the only symptom that we saw and go to the hospital and passed away,” said Earnest.
The Centers for Disease Control and Prevention has yet to list this as a symptom, but an infection in the eyes could cause conjunctivitis, according to the American Academy of Opthalmology.
From the observation, it appears that those who are infected with coronavirus have bloodshot eyes as if they are experiencing an allergic reaction. Experts say more research is needed to understand why a patient with coronavirus may have red or bloodshot eyes. However, patients who suffer from conjunctivitis may also have symptoms that are very similar to the coronavirus.
Nevertheless, health authorities advise constant hand washing and for those who are treating patients with coronavirus to keep their eyes, nose, and mouth protected. Disinfecting with hand sanitizers as well as constant disinfecting of items that are often touched are also advised.
Meanwhile, in the midst of the fear and worry surrounding the coronavirus, a breakthrough has been made amongst scientists towards the cure for the pandemic. A new report reveals that scientists found that the vaccine that could be used to treat the condition may be long-lasting.
A study conducted by researchers in Italy found that the strain of the coronavirus or COVID19 does not mutate quickly. This means that the vaccine that would be developed for the virus to prevent people from getting infected should be effective across the board over a long period of time.


Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates
Innovent’s Xinermei Intensifies Weight-Loss Drug Battle in China
U.S. Experts to Reassess Newborn Hepatitis B Vaccination Guidelines Amid Growing Debate
Eli Lilly’s Weight-Loss Pill Nears Fast-Track FDA Approval as Profits Surge on Global Demand
Trump Hints at Major Autism Announcement, Raises Questions on Tylenol Link
FDA Names Tracy Beth Høeg as Acting CDER Director After Richard Pazdur Announces Retirement
U.S. Reveals 2026 Medicare Star Ratings: Aetna, UnitedHealth Lead in Quality Scores
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits
Novo Nordisk Appoints Greg Miley as Global Head of Corporate Affairs Amid U.S. Pricing Pressure
Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market
Obamacare Premiums Set to Double in 2026 as Subsidy Expiration Looms Amid U.S. Shutdown
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio
Major Drugmakers Slash U.S. Prices and Sell Directly to Patients Amid Trump’s Push for Affordable Medicines 



